Thursday, February 27, 2014

Cellmid purchased

I have added a few shares in Cellmid (ASX: CDY) to the portfolio. Cellmid is a biotech company with several projects at various stages of development. As far as I am aware, none have reached the stage where they can be commercially exploited. There is an issuer sponsored research report here. Needless to say, this is a highly speculative investment.

I paid AUD0.033 per share for a small investment.


Troy said...

Hi there. Great blog. A company associated with Cellmid is Pacific Edge Biotech which has been having a bit of a run lately. A biotech with recently bought to market bladder cancer diagnostic kit. PEB on the NZX. Worth a look perhaps. I got in late last year at $0.62. Waiting on sales results at the moment, hopefully big things in the future. Cheers.

traineeinvestor said...

Hi Troy

Thanks for dropping by.

I had a look at PEB - it has done very well. Hopefully Cellmid will do as well.